Researchers used pediatric airway cells, blood vessel cells, and neutrophils to build an in vitro model of infant lungs that allowed them to investigate why respiratory syncytial virus makes infants sicker than adults, and to test new treatments. The post New Lung Model Reveals RSV Immune Response, Points to Better Treatments appeared first on GEN – Genetic Engineering and Biotechnology…
You may also like
SMC recommends VEOZA for moderate to severe menopausal...
SMC backs Columvi combination for second-line lymphoma...
Bristol Myers Squibb’s New Drug Application for...
Exonate appoints Olav Hellebø as CEO
Genetic Map Opens Door to Development of New Therapies...
StockWatch: Insilico Projects Profit, Revenue Leaps as...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.